Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
CC transcript
|
|
Chelsea Therapeutics International, Ltd. (CHTP)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/25/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/25/2014 |
4
| Hewitt L Arthur (Chief Scientific Officer) has filed a Form 4 on Chelsea Therapeutics International, Ltd. |
| 06/25/2014 |
4
| Rueckert William Dodge (Director) has filed a Form 4 on Chelsea Therapeutics International, Ltd. |
| 06/25/2014 |
4
| WEISER MICHAEL (Director) has filed a Form 4 on Chelsea Therapeutics International, Ltd.|
Txns:
| Unknown transaction of 450,178 shares
@ $0
Disposed/sold 27,500 shares
@ $0
Exercised 27,500 options to buy
@ $6.5, valued at
$178.8k
Disposed/sold 52,500 options to buy
@ $4.65, valued at
$244.1k
Disposed/sold 52,500 options to buy
@ $0.96, valued at
$50.4k
Disposed/sold 17,500 options to buy
@ $1.1, valued at
$19.3k
Disposed/sold 35,000 options to buy
@ $1.15, valued at
$40.3k
Disposed/sold 30,000 options to buy
@ $4.54, valued at
$136.2k
Disposed/sold 30,000 options to buy
@ $7.72, valued at
$231.6k
Disposed/sold 30,000 options to buy
@ $2.96, valued at
$88.8k
Disposed/sold 30,000 options to buy
@ $1.78, valued at
$53.4k
|
|
| 06/25/2014 |
4
| Clemens Kevan (Director) has filed a Form 4 on Chelsea Therapeutics International, Ltd.|
Txns:
| Unknown transaction of 5,000 shares
@ $0
Disposed/sold 35,000 options to buy
@ $4.65, valued at
$162.8k
Disposed/sold 35,000 options to buy
@ $0.96, valued at
$33.6k
Disposed/sold 35,000 options to buy
@ $1.15, valued at
$40.3k
Disposed/sold 40,000 options to buy
@ $4.54, valued at
$181.6k
Disposed/sold 40,000 options to buy
@ $7.72, valued at
$308.8k
Disposed/sold 40,000 options to buy
@ $2.96, valued at
$118.4k
Disposed/sold 40,000 options to buy
@ $1.78, valued at
$71.2k
Disposed/sold 42,500 options to buy
@ $6.5, valued at
$276.3k
Disposed/sold 42,500 options to buy
@ $5.68, valued at
$241.4k
Disposed/sold 30,000 options to buy
@ $3.26, valued at
$97.8k
|
|
| 06/25/2014 |
4
| Schmidt Keith (Chief Commercial Officer) has filed a Form 4 on Chelsea Therapeutics International, Ltd. |
| 06/25/2014 |
4
| Roberts Michael J (VP, Business Development) has filed a Form 4 on Chelsea Therapeutics International, Ltd. |
| 06/25/2014 |
4
| Oliveto Joseph (President and CEO) has filed a Form 4 on Chelsea Therapeutics International, Ltd. |
| 06/25/2014 |
4
| Riehle J Nick (CFO) has filed a Form 4 on Chelsea Therapeutics International, Ltd.|
Txns:
| Unknown transaction of 66,183 shares
@ $0
Disposed/sold 368,923 shares
@ $0
Exercised 50,000 options to buy
@ $6.5, valued at
$325k
Exercised 50,000 options to buy
@ $3.26, valued at
$163k
Exercised 50,000 options to buy
@ $2.96, valued at
$148k
Exercised 68,923 options to buy
@ $2.62, valued at
$180.6k
Exercised 50,000 options to buy
@ $1.78, valued at
$89k
Exercised 50,000 options to buy
@ $1.24, valued at
$62k
Exercised 50,000 options to buy
@ $0.96, valued at
$48k
Disposed/sold 50,000 options to buy
@ $7.72, valued at
$386k
Disposed/sold 50,000 options to buy
@ $5.68, valued at
$284k
|
|
| 06/25/2014 |
4
| Schwieterman William D (Chief Medical Officer) has filed a Form 4 on Chelsea Therapeutics International, Ltd.|
Txns:
| Unknown transaction of 130,592 shares
@ $0
Disposed/sold 350,000 shares
@ $0
Exercised 35,000 options to buy
@ $5.07, valued at
$177.5k
Exercised 50,000 options to buy
@ $4.65, valued at
$232.5k
Exercised 50,000 options to buy
@ $4.54, valued at
$227k
Exercised 10,000 options to buy
@ $2.96, valued at
$29.6k
Exercised 75,000 options to buy
@ $2.82, valued at
$211.5k
Exercised 30,000 options to buy
@ $1.78, valued at
$53.4k
Exercised 50,000 options to buy
@ $1.24, valued at
$62k
Exercised 50,000 options to buy
@ $0.96, valued at
$48k
Disposed/sold 50,000 options to buy
@ $7.72, valued at
$386k
|
|
| 01/30/2014 |
4
| Schmidt Keith (Chief Commercial Officer) has filed a Form 4 on Chelsea Therapeutics International, Ltd. |
| 01/24/2014 |
4
| Roberts Michael J (VP, Business Development) has filed a Form 4 on Chelsea Therapeutics International, Ltd. |
| 01/24/2014 |
4
| Schwieterman William D (Chief Medical Officer) has filed a Form 4 on Chelsea Therapeutics International, Ltd.|
Txns:
| Granted 50,000 options to buy
@ $4.65, valued at
$232.5k
|
|
| 01/24/2014 |
4
| Hewitt L Arthur (Chief Scientific Officer) has filed a Form 4 on Chelsea Therapeutics International, Ltd. |
| 01/24/2014 |
4
| Riehle J Nick (CFO) has filed a Form 4 on Chelsea Therapeutics International, Ltd.|
Txns:
| Granted 50,000 options to buy
@ $4.65, valued at
$232.5k
|
|
| 01/24/2014 |
4
| Oliveto Joseph (President and CEO) has filed a Form 4 on Chelsea Therapeutics International, Ltd. |
| 01/24/2014 |
4
| STOLL ROGER G PHD (Director) has filed a Form 4 on Chelsea Therapeutics International, Ltd. |
| 01/24/2014 |
4
| Rueckert William Dodge (Director) has filed a Form 4 on Chelsea Therapeutics International, Ltd. |
| 01/24/2014 |
4
| Clemens Kevan (Director) has filed a Form 4 on Chelsea Therapeutics International, Ltd.|
Txns:
| Granted 35,000 options to buy
@ $4.65, valued at
$162.8k
|
|
| 01/24/2014 |
4
| WEISER MICHAEL (Director) has filed a Form 4 on Chelsea Therapeutics International, Ltd.|
Txns:
| Granted 52,500 options to buy
@ $4.65, valued at
$244.1k
|
|
| 04/18/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/18/2013 |
4
| WEISER MICHAEL (Director) has filed a Form 4 on Chelsea Therapeutics International, Ltd.|
Txns:
| Granted 50,000 options to buy
@ $1.77, valued at
$88.5k
|
|
| 04/18/2013 |
4
| Rueckert William Dodge (Director) has filed a Form 4 on Chelsea Therapeutics International, Ltd. |
| 04/18/2013 |
4
| STOLL ROGER G PHD (Director) has filed a Form 4 on Chelsea Therapeutics International, Ltd.|
Txns:
| Granted 50,000 options to buy
@ $1.77, valued at
$88.5k
|
|
| 12/19/2012 |
4/A
| AUSTIN JOSIAH T (10% Owner) has filed a Form 4 on Chelsea Therapeutics International, Ltd.|
Txns:
| Sold 249,249 shares
@ $0.9501, valued at
$236.8k
Sold 439,308 shares
@ $0.9152, valued at
$402.1k
|
|
| 08/01/2012 |
4
| WEISER MICHAEL (Director) has filed a Form 4 on Chelsea Therapeutics International, Ltd.|
Txns:
| Granted 17,500 options to buy
@ $1.1, valued at
$19.3k
|
|
| 07/27/2012 |
4
| Clemens Kevan (Director) has filed a Form 4 on Chelsea Therapeutics International, Ltd.|
Txns:
| Granted 35,000 options to buy
@ $1.15, valued at
$40.3k
|
|
| 07/27/2012 |
4
| STOLL ROGER G PHD (Director) has filed a Form 4 on Chelsea Therapeutics International, Ltd.|
Txns:
| Granted 35,000 options to buy
@ $1.15, valued at
$40.3k
|
|
| 07/27/2012 |
4
| Rueckert William Dodge (Director) has filed a Form 4 on Chelsea Therapeutics International, Ltd. |
| 07/11/2012 |
4
| Oliveto Joseph (Interim President and CEO) has filed a Form 4 on Chelsea Therapeutics International, Ltd. |
| 07/11/2012 |
4
| Riehle J Nick (CFO) has filed a Form 4 on Chelsea Therapeutics International, Ltd.|
Txns:
| Granted 50,000 options to buy
@ $1.24, valued at
$62k
|
|
| 07/11/2012 |
4
| Hewitt L Arthur (Chief Scientific Officer) has filed a Form 4 on Chelsea Therapeutics International, Ltd. |
| 07/11/2012 |
4
| Schwieterman William D (Chief Medical Officer) has filed a Form 4 on Chelsea Therapeutics International, Ltd. |
| 07/11/2012 |
4
| Roberts Michael J (VP, Business Development) has filed a Form 4 on Chelsea Therapeutics International, Ltd. |
|
|
|